Analyst Coverage

Submenu

Firm	Analyst
Barclays	Peter Lawson, DPhil (Oxon)
Brookline Capital Markets	Leah Cann
Cantor Fitzgerald	Li Watsek
Cowen and Company	Phil Nadeau, Ph.D.
Credit Suisse	Tiago Fauth
H.C. Wainwright & Co.	Joseph Pantginis, Ph.D.
Jefferies	Roger Song, M.D., CFA
JMP Securities	Reni Benjamin, Ph.D.
Stifel	Brad Canino
SVB Securities	Jonathan Chang, Ph.D., CFA
Wedbush	Robert Driscoll, Ph.D.

Kura Oncology, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Kura Oncology, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kura Oncology, Inc. or its management. Kura Oncology, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121